The VERIZAP brand, founded in 2013 (Switzerland), from 2951 sister brands and 17477 competing brands. VERIZAP is owned by NOVARTIS N, listed on the stock exchange of Zurich Its International Securities Identification Number (ISIN) is CH0012005267. VERIZAP belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(VERIZAP)
over 5 years*
CHF 101.63